PubRank

An-Suei Yang

Author PubWeight™ 22.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation. J Biol Chem 2001 1.78
2 The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J Gen Physiol 2004 1.77
3 Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis 2004 1.09
4 Modeling protein loops with knowledge-based prediction of sequence-structure alignment. Bioinformatics 2007 1.09
5 Rationalization and design of the complementarity determining region sequences in an antibody-antigen recognition interface. PLoS One 2012 1.06
6 E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors. Proc Natl Acad Sci U S A 2011 1.04
7 Protein backbone angle prediction with machine learning approaches. Bioinformatics 2004 1.04
8 Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors. ACS Chem Biol 2010 0.98
9 Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. J Am Chem Soc 2007 0.97
10 Protease substrate site predictors derived from machine learning on multilevel substrate phage display data. Bioinformatics 2008 0.90
11 Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses. Bioorg Med Chem 2010 0.89
12 Amino acid substitutions of MagA in Klebsiella pneumoniae affect the biosynthesis of the capsular polysaccharide. PLoS One 2012 0.88
13 Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4. J Biol Chem 2011 0.88
14 A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity. J Am Chem Soc 2011 0.88
15 Assessing computational amino acid beta-turn propensities with a phage-displayed combinatorial library and directed evolution. Structure 2006 0.85
16 Factor Xa active site substrate specificity with substrate phage display and computational molecular modeling. J Biol Chem 2008 0.84
17 Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries. J Biol Chem 2010 0.84
18 Protein-protein interaction site predictions with three-dimensional probability distributions of interacting atoms on protein surfaces. PLoS One 2012 0.82
19 Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. Bioorg Med Chem 2008 0.81
20 Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. Chembiochem 2007 0.80
21 Prediction of carbohydrate binding sites on protein surfaces with 3-dimensional probability density distributions of interacting atoms. PLoS One 2012 0.80
22 Signal sequence as a determinant in expressing disulfide-stabilized single chain antibody variable fragments (sc-dsFv) against human VEGF. Mol Biosyst 2010 0.77
23 Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders. Structure 2009 0.77
24 Design of phage-displayed cystine-stabilized mini-protein libraries for proteinaceous binder engineering. Methods Mol Biol 2014 0.75
25 Substrate phage display for protease substrate sequence characterization: bovine factor Xa as a model system. Methods Mol Biol 2014 0.75
26 Effects of signal sequence on phage-displayed disulfide-stabilized single chain antibody variable fragment (sc-dsFv) libraries. Biochem Biophys Res Commun 2011 0.75